Challenges for a crucial sickle cell treatment and the latest outlook for GLP-1s

This week on "The Readout LOUD": We discuss financial outlooks from Novo Nordisk and Eli Lilly, a closer look at why manufacturing problems have slowed the rollout of a crucial…